Investigation on the effects of ciclosporin (Atopica) on intradermal test reactivity and allergen-specific immunoglobulin (IgE) serology in atopic dogs

Veterinary Dermatology

Volumn 21, Issue 4, 2010, Pages 393-399

  Goldman, Candice ^a   Rosser Jr, Edmund ^a   Petersen, Annette ^a   Hauptman, Joe ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CYCLOSPORIN; IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; ATOPIC DERMATITIS; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOG; DOG DISEASE; DOUBLE BLIND PROCEDURE; IMMUNOLOGY; INTRACUTANEOUS TEST; RANDOMIZED CONTROLLED TRIAL;

ALLERGENS; ANIMALS; CROSS-OVER STUDIES; CYCLOSPORINE; DERMATITIS, ATOPIC; DOG DISEASES; DOGS; DOUBLE-BLIND METHOD; IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENTS; INTRADERMAL TESTS;

ANIMALIA; CANIS FAMILIARIS;

EID: 77954354364     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2009.00862.x     Document Type: Article

References (30)

1. Hill PB, Olivry T. The ACVD task force on canine atopic dermatitis (V): biology and role of inflammatory cells in cutaneous allergic reactions. Veterinary Immunology and Immunopathology 2001, 81:187-98.
2. Scott DW. Observations on canine atopy. Journal of the American Animal Hospital Association 1981, 17:91-100.
3. DeBoer DJ. Survey of intradermal skin testing practices in North America. Journal of the American Veterinary Medical Association 1998, 195:1357-63.
4. Hillier A, Griffin CE. The ACVD task force on canine atopic dermatitis (I): incidence and prevalence. Veterinary Immunology and Immunopathology 2001, 81:147-51.
5. van Joost T, Stolz E, Heule F. Efficacy of low-dose cyclosporine in severe atopic skin disease. Archives of Dermatology 1987, 123:166-7.
6. Fontaine J, Olivry T. Treatment of canine atopic dermatitis with cyclosporine: a pilot clinical study. Veterinary Record 2001, 148:662-3.
7. Olivry T, Steffan J, Fisch RD. Randomized controlled trial of the efficacy of cyclosporine in the treatment of atopic dermatitis in dogs. Journal of the American Veterinary Medical Association 2002, 221:370-7.
8. Olivry T, Rivierre C, Jackson HA. Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial. Veterinary Dermatology 2002, 13:77-87.
9. Stahelin H. Cyclosporin A. Historical background. Progress in Allergy 1986, 38:19-27.
10. Hijnen DJ, Berge O, Timer-de Mik L. Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis. Journal of the European Academy of Dermatology and Venereology 2007, 21:85-9.
11. Olivry T, Mueller RS. Evidence-based veterinary dermatology: a systematic review of the pharmacotherapy of canine atopic dermatitis. Veterinary Dermatology 2003, 14:121-46.
12. Ichiro K. Current concept of steroid tachyphylaxis in the skin. Japanese Journal of Dermatology 2004, 114:2088-92.
13. du Vivier A, Stoughton RB. Tachyphylaxis to the action of topically applied corticosteroids. Archives of Dermatology 1975, 111:581.
14. Radowicz SN, Power HT. Long-term use of cyclosporine in the treatment of canine atopic dermatitis 2005, 16:81-6.
15. Kuroha M, Kuze Y, Shimoda M. In vitro characterization of the inhibitory effects of ketoconazole on metabolic activities of cytochrome P-450 in canine hepatic microsomes. American Journal of Veterinary Research 2002, 63:900-5.
16. Guaguere E, Steffan J, Olivry T. Cyclosporin A: a new drug in the field of canine dermatology. Veterinary Dermatology 2004, 15:61-74.
17. Steffan J, Parks C, Seewald W. Clinical trial evaluating the efficacy and safety of cyclosporine in dogs with atopic dermatitis. Journal of the American Veterinary Medical Association 2005, 226:1855-63.
18. Steffan J, Horn J, Gruet P. Remission of the clinical signs of atopic dermatitis in dogs after cessation of treatment with cyclosporine or methylprednisolone. Veterinary Record 2004, 154:681-4.
19. Marsella R, Nicklin CF, Saglio S. Investigation on the effects of topical therapy with 0.1% tacrolimus ointment (Protopic®) on intradermal skin test reactivity in atopic dogs. Veterinary Dermatology 2004, 15:218-24.
20. Burton G, Robson D, Bassett R. A pilot trial on the effect of cyclosporine on intradermal skin testing in dogs with atopic dermatitis. Proceedings of the 17th Annual Meeting of the American College and the American Academy of Veterinary Dermatology 2002, In, New Orleans, LA
21. Clarke K, McCall C, Steffan J. The effects of cyclosporine A and oral prednisolone on flea allergen specific serum IgE and intradermal test in experimentally sensitized laboratory Beagles. Veterinary Dermatology. 2003, 14:248.
22. Munro CS, Higgins EM, Marks JM. Cyclosporin A in atopic dermatitis: therapeutic response is dissociated from effects on allergic reactions. British Journal of Dermatology 1991, 124:43-8.
23. Rosser EJ. Comparison of intradermal testing and allergen-specific IgE serum testing in dogs with warm weather, seasonal atopic dermatitis. Advances in Veterinary Dermatology Vol. 5 2005, 42-59. Hillier AFoster APKwochka KW. In, eds, Vienna, Austria
24. Taylor AM, Galli SJ, Coleman JW. Dexamethasone or cyclosporin A inhibits stem cell factor-dependent secretory responses or fat peritoneal mast cells in vitro. Immunopharmacology 1996, 34:63-70.
25. Stellato C, Paulis A, Ciccarelli A. Anti-inflammatory effect of cyclosporin A on human skin mast cells. Journal of Investigative Dermatology 1992, 98:800-4.
26. Hess AD. Mechanisms of action of cyclosporine: considerations for the treatment of autoimmune diseases. Clinical Immunology and Immunopathology 1993, 68:220-8.
27. Stellato C, Depaulis A, Ciccarelli A. Anti-inflammatory effect of cyclosporine-A on human skin mast cells. Journal of Investigative Dermatology 1992, 98:800-4.
28. Cirillo R, Triggiani M, Siri L. Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin. Journal of Immunology 1990, 144:3891-7.
29. Chen SA, Li Q, Pearlman E. Dual mechanisms of potentiation of murine antigen-specific IgE production by cyclosporine A in vitro. Journal of Immunology 1992, 149:762-7.
30. Garcia G, Ferrer L, De Mora F. Inhibition of histamine release from dispersed canine skin mast cells by cyclosporine-A, rolipram and salbutamol, but not by dexamethasone or sodium cromoglycate. Veterinary Dermatology 1998, 9:81-6.